Vaccinology in Africa - A Virtual Master's Level Course


This course has been developed in close collaboration with leading clinicians, veterinarians and industrial partners in vaccinology.

The programme provides state-of-the-art teaching in both human and veterinary vaccinology, drawing on the experience of the Jenner Institute at the University of Oxford, The Pirbright Institute, and the course’s virtual co-host, the KEMRI Wellcome Trust Research Programme in Kenya.

These courses alternate between East and West Africa. In 2021, participation is limited to attendants currently working or studying in East Africa.

Attendance is free to participants. Places are limited and participants will be selected based on their relevant experience and background within the vaccine field, as detailed in the application form below.

You must apply in advance to attend this course. Click the ‘Apply’ button for details.

Applications will close on 31 August 2021.

Programme details

Each day is delivered as five one-hour sessions, with half-hour breaks in between and a one-hour lunch break.

There will also be dedicated time at the end of each day for a Q&A session with the speakers of the day.

The below programme is provisional and may be subject to change.

Day 1 - Principles of Vaccinology - 4 October

  • Opening keynote: Vaccine R&D and manufacturing in Africa 
  • Introduction to vaccine design & structural vaccinology
  • Vaccine Immunology

  • New vaccine vectors and VLPs 
  •  Veterinary vaccines - latest technologies

Day 2 – Principles of Vaccinology - 5 October

  • RNA technologies in vaccine design
  • Protein expression vaccine technologies
  • Nutrition and vaccine responses 
  • Maternal Immunisation
  • Virtual workshop on Vaccine Design 

Day 3 - Vaccine Technologies and their Development - 6 October

  • Progress with pneumococcal vaccines  
  • Foot-and-Mouth Disease Virus: Vaccine Research to Commercial Development
  • Development of a One Health vaccine against Rift Valley Fever
  • Progress with meningococcal vaccines  

Day 4 - Vaccine Technologies and their Development - 7 October

  • Design and pre-clinical testing of a Covid-19 vaccine and other outbreak pathogen vaccines
  • Clinical development of a COVID-19 vaccine
  • Vaccine manufacturing: General principles and case study from COVID-19
  • Developing a vaccine against Ebola
  • Subunit vaccine technology: Developing a vaccine against African swine fever

Day 5 - Major Vaccine Targets - 8 October

  • HIV vaccines
  • TB Vaccines
  • Vaccination against East Coast Fever and CBPP 
  • Yellow Fever and other vaccine R&D at Institut Pasteur de Dakar 
  • Arboviral vaccines 

Day 6 – Major Vaccine Targets - 11 October

  • Poxvirus diseases of livestock 
  • Malaria vaccines 
  • Controlled Human Malaria Infection studies in Africa
  • HPV vaccines
  • Vaccines for enteric pathogens  

Day 7 – Vaccine Development, Policy and Clinical Trials - 12 October

  • Vaccine development in Africa: preclinical to field trials
  • Immunomonitoring in clinical vaccine trials
  • Developing a field trial site: Ghana 
  • Undertaking trials of new vaccines in Africa and their public engagement challenges
  • Regulation and oversight of clinical vaccine trials in Africa

Day 8 – Vaccine Development, Policy and Clinical Trials - 13 October

  • Veterinary Vaccine Development in Africa
  • Capacity building for biomedical research in Africa
  • Research & career perspectives from the pharma industry
  • Vaccines research funding policy in Africa
  • Vaccine access and cost-effectiveness in Africa

Day 9 – Vaccine Development in Africa​ - 14 October

  • Human vaccine development and manufacturing in South Africa
  • Strengthening innovation systems and IP development in Africa
  • Statistical analysis of vaccine trials
  • Priorities for veterinary vaccine development in Africa
  • Building capacity for human vaccine manufacturing in Africa – a strategic and funding perspective

Day 10 - Vaccine Development In Africa - 15 October

  • Livestock vaccines for Africa: a manufacturing outlook
  • Accelerating vaccine research in Africa 
  • Practical, regulatory and ethical issues in vaccine development & deployment: the Kenya experience
  • Careers in vaccine R&D in Africa
  • Discussion Panel: Career and funding opportunities for vaccine researchers in Africa and beyond


Participants who satisfy the course requirements will receive a University of Oxford electronic certificate of attendance. To receive a certificate at the end of the course you will need to achieve a minimum attendance of 75% of the online sessions.

Attendance will be monitored throughout the sessions.

The certificate will show your name, the course title and the dates of the course you attended.


Description Costs
Course Fee £0.00


Dr Moses Alobo

African Academy of Sciences

Prof William Ampofo

Noguchi Memorial Institute for Medical Research, Ghana

Prof Edwine Barasa

KEMRI Wellcome Trust Research Programme, Nairobi/ Centre for Tropical Medicine & Global Heal , University of Oxford

Dr Pip Beard

The Pirbright Institute

Prof Bryan Charleston

Director, The Pirbright Institute and Investigator, Jenner Institute, University of Oxford

Dr Lucy Dorrell

Jenner Institute, University of Oxford

Dr Sandy Douglas

Jenner Institute, University of Oxford

Prof Simon Draper

Department of Biochemistry, University of Oxford

Prof Alison Elliott

Medical Research Council / Uganda Virus Research Institute (UVRI) and London School of Hygiene & Tropical Medicine

Dr Helen Fletcher

Senior Lecturer in Immunology, London School of Hygiene and Tropical Medicine

Prof Sarah Gilbert

Jenner Institute, University of Oxford

Dr Rebecca Grais

Epicentre, Médecins Sans Frontières

Dr Mainga Hamaluba

Chair of Clinical Research, KEMRI-Wellcome Trust Research Programme, Kenya & Centre for Tropical Medicine & Global Health, University of Oxford

Prof Adrian Hill

Director, The Jenner Institute, University of Oxford

Dr David Jeffries

MRC Unit The Gambia at London School of Hygiene & Tropical Medicine

Dr Florian Krammer

Icahn School of Medicine at Mount Sinai, New York

Dr Teresa Lambe

Jenner Institute, University of Oxford

Prof Jenniffer Mabuka-Maroa

Department of Global Health, University of Washington

Prof Calman MacLennan

Jenner Institute, University of Oxford and Gates Foundation

Prof Shabir Mahdi

Faculty of Health Sciences, University of the Witwatersrand, Johannesburg

Dr Diadié Maïga

Regional Vaccine Regulatory Officer, WHO

Dr Morena Makhoana

The Biovac Institute, Cape Town

Prof Helen McShane

Jenner Institute, University of Oxford

Dr Furaha Mramba

Hester Biosciences Africa

Prof Julius Mugwagwa

University College London

Ms Noni Mumba

KEMRI Wellcome Trust Research Programme/ Centre for Tropical Medicine & Global Health, University of Oxford

Prof Thumbi Ndung'u

HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, South Africa

Dr Vish Nene

International Livestock Research Institute (ILRI), Nairobi

Dr Christopher Netherton

The Pirbright Institute

Prof Andrew Pollard

Director, Oxford Vaccine Group, University of Oxford

Dr Arturo Reyes

Instituto Politécnico Nacional, Mexico

Prof Mahamadou Thera

University of Bamako

Prof Halidou Tinto

Institut de Recherche en Science de la Santé-Unité de Recherche Clinique de Nanoro (IRSS)

Dr Caroline Trotter

University of Cambridge

Dr Tonya Villafana

AstraZeneca, Bethesda, Maryland, USA

Dr George Warimwe

Group Head / PI, University of Oxford


You must currently be working or studying in East Africa to apply for this course. Places are limited and participants will be selected based on their relevant experience and background within the vaccine field.

To apply for this course, please complete the application form.

Applications will close on 31 August 2021.

IT requirements

This course is delivered online using Microsoft Teams. You will be required to follow and implement the instructions we send you to fully access Microsoft Teams on the University of Oxford's secure IT network.

This course is delivered online; to participate you will need regular access to the Internet and a computer meeting our recommended Minimum computer specification.

It is advised to use headphones with working speakers and microphone.

You will not be required to purchase any specific software to take part in this course.